Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploring the Wound Healing Potential of Hispidin.
Liu YS, Lai MC, Hong TY, Liu IM. Liu YS, et al. Among authors: liu im. Nutrients. 2024 Sep 19;16(18):3161. doi: 10.3390/nu16183161. Nutrients. 2024. PMID: 39339761 Free PMC article.
Geographic differences in susceptibility profiles of potential non-class B carbapenemase-producing Enterobacterales isolates against ceftazidime-avibactam, meropenem-vaborbactam, colistin, amikacin, gentamicin, and tigecycline: Data from the Antimicrobial Testing Leadership and Surveillance, 2018-2022.
Jean SS, Ko WC, Liu IM, Hsieh PC, Hsueh PR. Jean SS, et al. Among authors: liu im. Int J Antimicrob Agents. 2024 Dec;64(6):107363. doi: 10.1016/j.ijantimicag.2024.107363. Epub 2024 Oct 24. Int J Antimicrob Agents. 2024. PMID: 39455015
Distributions of plasmidic genes encoding extended-spectrum and AmpC β-lactamases, and susceptibilities of global non-carbapenemase-producing meropenem-resistant Enterobacterales to ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam-avibactam, 2017-2022.
Jean SS, Chang HT, Huang CL, Liu IM, Hsieh PC, Hsueh PR. Jean SS, et al. Among authors: liu im. J Infect. 2024 Dec 30;90(2):106380. doi: 10.1016/j.jinf.2024.106380. Online ahead of print. J Infect. 2024. PMID: 39742976 Free article. No abstract available.
Bacterial profile, and independent predictors for healthcare-associated pneumonia persistently caused by multidrug-resistant Gram-negative bacteria for patients with the preceding multidrug-resistant Gram-negative pneumonia in Taiwan.
Kuo LK, Chang HT, Hsueh SC, Liu IM, Hsieh PC, Jean SS. Kuo LK, et al. Among authors: liu im. J Microbiol Immunol Infect. 2024 Oct;57(5):801-811. doi: 10.1016/j.jmii.2024.07.009. Epub 2024 Aug 6. J Microbiol Immunol Infect. 2024. PMID: 39147627 Free article.
Potentially effective antimicrobial treatment for pneumonia caused by isolates of carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii complex species: what can we expect in the future?
Jean SS, Liu CY, Huang TY, Lai CC, Liu IM, Hsieh PC, Hsueh PR. Jean SS, et al. Among authors: liu im. Expert Rev Anti Infect Ther. 2024 Dec;22(12):1171-1187. doi: 10.1080/14787210.2024.2412637. Epub 2024 Oct 9. Expert Rev Anti Infect Ther. 2024. PMID: 39381911 Review.
In vitro antimicrobial susceptibility data of global meropenem-resistant Acinetobacter baumannii isolates causing pneumonia: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2014-2021, and re-estimations of susceptibility breakpoints and appropriate dosages of important antibiotics for pneumonia treatment.
Hsueh SC, Huang YT, Ko WC, Liu IM, Hsieh PC, Jean SS. Hsueh SC, et al. Among authors: liu im. J Glob Antimicrob Resist. 2024 Mar;36:411-418. doi: 10.1016/j.jgar.2024.01.019. Epub 2024 Feb 6. J Glob Antimicrob Resist. 2024. PMID: 38331030 Free article.
212 results